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Opportunities for FDA Regulation of CBD in Food
Products 1
Hannah Catt*
Abstract
After the passage of the 2018 Farm Bill, champions of hemp
began to tout opportunities for farmers and businesses involved with
the crop. The industry has rallied around one of hemp’s major
byproducts, cannabidiol, or CBD. However, the demand for CBD
has left the Food and Drug Administration (“FDA”) playing catchup. This article explains what CBD is, how it is derived, current
FDA-approved uses, and a current path forward for the FDA in
creating guidance for industry and consumers.
I. Introduction
It is difficult today to read the news, browse social media, or
even shop in some stores without encountering people extolling the
virtues of cannabidiol (“CBD”) or questioning its therapeutic value. 2
The Food and Drug Administration has been challenged by the
proliferation of CBD in many markets. The hype has not escaped the
FDA’s notice, but a federal agency is not poised to quickly respond
to trends like these, therefore, the agency has yet to promulgate a full
set of regulations.
The production and use of CBD involve competing interests,
from the pharmaceutical sector, food producers, farmers, and
consumers. Each of these parties has an interest in regulations being
developed sooner rather than later, in part because there is currently
significant market opportunity for CBD products. This article
explores the following issues relating to CBD: what CBD is; how it
is different from other cannabis products; what CBD is being used
for; and how the federal government can appropriately regulate the
production and use of the product. Due to the limited existing
research on the effects of CBD, the best option may be for the FDA

* Hannah Catt holds a J.D. with certificates in Environmental and Health Law from
the University of Maryland Francis King Carey School of Law, as well as an LL.M.
in Agricultural & Food Law from the University of Arkansas School of Law.
1
Some companies that market CBD products are mentioned by name in this article.
No mention of a specific company serves as an endorsement; it is purely for
illustrative purposes.
2
See, e.g., Alex Williams, Why is CBD Everywhere?, N.Y. TIMES (Oct. 7, 2018),
https://www.nytimes.com/2018/10/27/style/cbd-benefits.html.
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to allow CBD to be sold as a supplement in limited concentrations
while also working towards new drug approvals.
II. Hemp and Cannabinoids
In recent years, many states have legalized medicinal and/or
recreational marijuana use. 3 Recent legislation expanding programs
for legal hemp production has increased interest in by-products of
the plant beyond traditional, industrial uses. 4 Despite the differences
in the use and availability of marijuana and hemp, the two are
inextricably linked, usually under the banner of “cannabis.” While
confusing, this is not a mistake. Marijuana and hemp are both
products of Cannabis sativa, however, they are distinguishable based
on their relative concentration of tetrahydrocannabinol (“THC”). 5
The plants can also be distinguished by their physical features when
growing, as explained in Section II.
Marijuana is often consumed for the psychoactive effects of
THC, which is present in varying amounts based on the plant variety
or cultivar. 6 CBD is commonly considered non-psychoactive
because it does not produce the “high” associated with consuming
marijuana. 7 In his work, prominent cannabis researcher Dr. Ernest
Small has clarified that this common usage of the term nonpsychoactive for describing CBD is not proper because any
significant change in mental state, including anxiety changes, should
be considered a psychoactive effect. 8
CBD and THC are also both cannabinoids, a chemical
component of the cannabis sativa plant. 9 While cannabinoids have
been found in other plants, CBD is noted as the “principal
cannabinoid of hemp.” 10 There have been over 100 cannabinoids
identified in cannabis. 11 The cannabinoids act by binding to

3
NAT’L CONF. OF STATE LEGISLATURES, MARIJUANA OVERVIEW (2019),
http://www.ncsl.org/research/civil-and-criminal-justice/marijuana-overview.aspx.
4
7 U.S.C. § 5940 (2018).
5
CONG. RES. SERV., Defining Hemp: A Fact Sheet 1 (March 22, 2019), https://fas.org
/sgp/crs/misc/R44742.pdf.
6
Variety is technically used to note the plant types that are found in nature, while
cultivars are bred for specific characteristics. Id. (citing Cindy Haynes, Cultivar
Versus Variety, IOWA ST. UNIV. HORTICULTURE & HOME PEST NEWS (Feb. 6, 2008),
https://hortnews.extension.iastate.edu/2008/2-6/CultivarOrVariety.html).
7
ERNEST SMALL, CANNABIS: A COMPLETE GUIDE 204 (2016).
8
Id.
9
Id. at 205.
10
Id.
11
Genevieve Lafaye, et al., Cannabis, Cannabinoids, and Health, 19 DIALOGUES IN
CLINICAL NEUROSCIENCE 3, 309 (2017).
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receptors in the body’s endocannabinoid system. 12 This system and
the resulting effects of cannabinoids in the body were not discovered
until the late twentieth century. 13
CB1 and CB2 are both found in the central nervous system
and various organs throughout the body. 14 Because of the relatively
recent discovery of the endocannabinoid system and the many
restrictions around research related to cannabis, a full understanding
of the effects of cannabinoids is still developing. The different
receptor locations where the binding takes place can impact the
ultimate effects of cannabis consumption, the potency of the product,
and how CBD and THC will impact the body. 15
An additional area of study is how different cannabinoids
work together. Those involved in the illicit trade or consumption of
marijuana are seeking out a higher THC content, which will increase
the psychoactive effects. New strains of cannabis have been bred to
have a higher THC content at the expense of the CBD content. In
the reverse, cannabis bred for fiber or oilseed has high CBD content
and minimal THC. 16 Further, manufacturers of marijuana edibles do
not currently have an incentive to add CBD to the final product. 17
This may change as more is discovered about the combined effects
of THC and CBD, referred to as “entourage” or “ensemble” effects. 18
Consumption of THC and CBD has been shown to lessen some of
the psychoactive symptoms of THC. 19 The reason for this is not
immediately clear, but researchers have noticed this in patients who
take approved drugs with THC, such as Marinol, an appetite
stimulant primarily prescribed for patients with AIDS.20
CBD is produced through an extraction process which
should be highly monitored to ensure there is no THC present. To
Pál Pacher, et al., The Endocannabinoid System as an Emerging Target of
Pharmacotherapy, 58 PHARMACOL REV. 3, 389 (2006).
13
Matt Simon, THC! CBD! Terpenoids! Cannabis Science is Getting Hairy, WIRED
(Nov. 6, 2018), https://www.wired.com/story/cannabis-science-entourage-effect/.
14
Id.
15
SMALL, supra note 7, at 304–06.
16
Id. at 208.
17
Simon, supra note 13.
18
Some researchers prefer the term “ensemble effect” because it does not suggest
that THC is the most important cannabinoid for the endocannabinoid system
response. Simon, supra note 13.
19
Ethan B. Russo, Taming THC: Potential Cannabis Synergy and Phtocannabinoid
Terpenoid Entourage Effects, 163 BRIT. J. PHARMACOLOGY 1344, 1354 (2011).
20
Simon, supra note 13; Pácher, et al., supra note 12, at Table 1 (reporting that
patients taking Marinol experienced improvement in the areas of “spasticity, pain,
and sleep quality” and “was found to suppress otherwise intractable cholestatic
pruritus in a case report”).
12
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extract the CBD, hemp plants are harvested and then left to cure for
a few weeks. 21 The flower of the plant is then removed and sent to a
processor. 22 The processor grinds the flowers, then steeps them to
remove some terpenoids. 23 After a cold treatment, it is distilled,
sometimes twice, to achieve the right color and purity. 24 Many
brands have their products tested to guarantee purity and low or no
THC content. 25
III. Examining Hemp Production
The revenue that states and businesses have generated from
selling recreational marijuana is frequently labeled as a “Green
Rush.”26 The value of the CBD market could be a second wave in
this rush because it is worth around half a billion dollars today and
has the potential to reach twenty billion dollars by 2020. 27 However,
hemp has a long history of use for other industrial purposes and has
proven to be a versatile crop. 28 Hemp uses less inputs than a more
traditional crop like corn. 29 Once out of the initial development time,
producers use less water, pesticides, and fertilizers. 30 The terpenoids
Eric Hurlock, Harvesting, Drying, Trimming, & Curing Industrial Hemp Flower,
LANCASTER FARMING (Sep. 3, 2019), https://www.lancasterfarming.com (search
article name) (discussing measures a farm takes to monitor CBD and THC levels in
hemp flowers prior to harvest); Rajul Punjabi, There’s CBD in Everything so We
Found Out How It’s Made, VICE (Oct. 23, 2018), http://www.vice.com/en_us/article
/wj9knb/i-visited-a-cannabis-farm-to-find-out-how-cbd-oil-is-made.
22
Punjabi, supra note 21.
23
Id.
24
Id.
25
Medterra is an example of this. This company sources all of its hemp from
products grown as a part of the Kentucky Department of Agriculture Pilot Program.
Frequently Asked Questions, MEDTERRA, https://medterracbd.com/faq (last visited
Nov. 9, 2019) (linking interested consumers to the third-party lab test results of the
company’s CBD products).
26
See, e.g., Nick Kovacevich, Green Rush: How Legal Hemp Opens the Door for
Cannabis Investment, FORBES (Aug. 8, 2019), https://www.forbes.com (search
article title).
27
Brian Barth, The Rise and Rise of the Artisanal Hemp Farm. From Seed-to-CBD,
Our Writer Doses Up Then Files This Report, MODERN FARMER (Feb. 25, 2019),
https://modernfarmer.com/2019/02/the-rise-and-rise-of-the-artisanal-hemp-farm-fr
om-seed-to-cbd-our-writer-doses-up-then-files-this-report/.
28
Ernest Small & David Marcus, Hemp: A New Crop with New Uses for North
America, in TRENDS IN NEW CROPS AND NEW USES 284-326 (J. Janick & A Whipkey
eds., 2002), https://www.hort.purdue.edu/newcrop/ncnu02/v5-284.html (describing
some of the historical uses of hemp in industry).
29
Logan Yonavjak, Industrial Hemp: A Win-Win For the Economy and the
Environment, FORBES (May 29, 2013), https://www.forbes.com/ (search “Industrial
Hemp Win Win” and select the first result); Brian Barth, So, You Want to Be a Hemp
Farmer?, MODERN FARMER (July 9, 2018), https://www.modernfarmer.com/2018/0
7/so-you-want-to-be-a-hemp-farmer/.
30
Id.
21
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that give cannabis its unique smell have also been found in other
plants as a method of insect deterrent. 31 Hemp plants grow tall,
occasionally up to sixteen feet. 32 Plant height is one way to easily
distinguish hemp from marijuana, with the latter usually being short
and stubby. 33
Once harvested, hemp can be made into almost 25,000
different products in categories including: textiles, automotive parts,
food and beverages, and personal care products. 34 Most of the hemp
going into these products had to be imported though, due to
restrictions on growing hemp. 35 China accounts for the largest share
of production, growing roughly one-fifth of the world supply and
importing the most to the United States (“U.S.”). 36 Hemp fiber and
seeds can have returns of up to $700 per acre or $1,200 per acre,
respectively. 37 The total market value is approaching one billion
dollars. 38 The opportunity to grow hemp for use in American
industry and processing is an attractive one, and it presents a valuable
market opportunity for potential hemp farmers. 39 The history of
hemp production shows that there are many uses for the crop beyond
focusing exclusively on CBD. The CBD market could collapse at
any time or be severely restricted if the FDA takes a more aggressive
stance on non-prescribed uses of the compound.
China has historically produced large volumes of hemp, and
evidence suggests that they have been growing it for anywhere from
six to ten thousand years. 40 Hemp was spread from China to Western
Asia and Egypt, and then to Europe. 41 The crop did not arrive in
North America until the seventeenth century. 42 From approximately
that time until the nineteenth century, hemp was at its peak, being
used for textiles, paper, and even sails for ships. 43 Many reasons are
suggested for its decline in popularity, including the labor involved
Russo, supra note 19, at 349.
Cheryl Thayer et al., Industrial Hemp: From Seed to Market, HARVEST N.Y.,
(2017), http://putknowledgetowork.org/resources/industrial-hemp-from-seed-to-ma
rket.
33
Id.
34
Id.
35
Id.
36
Id.
37
CONG. RES. SERV., supra note 5, at 8.
38
The U.S. Hemp Industry Grows to $820mm in Sales in 2017, HEMP BUS. J., (2017),
hempbizjournal.com/size-of-us-hemp-industry-2017/.
39
Comparing it to grain, Brian Barth asserts that fifty acres should be a minimum
for growing hemp to retain profitability. Barth, supra note 29.
40
SMALL, supra note 7, at 91.
41
Id. at 92.
42
Id.
43
Id. at 93–94.
31
32
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with cultivation, cheaper fibers becoming available during the
Industrial Revolution, and the decreased use of sailing ships in favor
of fuel-powered ships. 44
Until the 2014 Farm Bill hemp provisions, hemp was
regulated along with marijuana. 45 Hemp was listed as a Schedule I
substance under the Controlled Substances Act (“CSA”), and the
Drug Enforcement Administration (“DEA”) provided oversight. 46
This classification required anyone who wanted to grow hemp to get
approval from the DEA, but applications were usually not
approved. 47 One early university research plot was approved in
North Dakota, but it involved significant costs. 48 Similar to states
choosing to allow recreational marijuana consumption while it is
restricted federally, states could create their own policies to allow
hemp cultivation if a DEA license was granted.
Hemp provisions found in the 2014 Farm Bill created an
agricultural pilot program “to study the growth, cultivation, or
marketing of industrial hemp.” 49 While states are allowed to create
their own regulations for programs, growing sites have to be
registered with and certified by the state’s department of agriculture,
and the growing is limited to research purposes of agriculture
departments or colleges and universities. 50 “Industrial hemp” is
defined as cannabis sativa with less than 0.3% THC on a dry weight
basis. 51 This figure is widely used to distinguish hemp from
marijuana. The THC amount was proposed by Ernest Small, who
indicated that, at 1% THC presence, marijuana begins to have
“intoxicating potential.”52 In addition to the U.S., Canada and
portions of Europe and Australia use the same threshold.53 Small is
quick to note this is a low threshold but contends that this makes it

Id. at 94.
CONG. RES. SERV., supra note 5, at 3–4.
46
21 U.S.C § 812 (b)(1) (2018) (providing that Schedule I substances have “a high
potential for abuse,” “no currently accepted medical use in treatment in the United
States,” and a “lack of accepted safety for use of the drug or other substance under
medical supervision.”)
47
Christine A. Kolosov, Evaluating the Public Interest: Regulation of Industrial
Hemp Under the Controlled Substances Act, 57 UCLA L. REV. 237, 247 (2009)
(providing an overview of the legal status of hemp cultivation over time in the U.S.
and explaining how state programs to allow cultivation are limited by DEA
approval).
48
Id.
49
7 U.S.C. § 5940.
50
Id. § 5940(A)–(B).
51
Id.
52
SMALL, supra note 7, at 208.
53
Id.
44
45
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highly unlikely that hemp would be repurposed for illegal
consumption. 54
The 2018 Farm Bill loosened the restrictions on hemp
further, officially removing it from the federal schedule of controlled
substances. 55 Because it was removed from the schedule, the DEA
also cannot interfere with the passage of hemp across state lines.56
Growers still have to operate under a state pilot program, of which
there are currently forty-one. 57
Kentucky was an early leader in the U.S. hemp market after
pilot program rules were released in the 2014 Farm Bill. State law
requires producers, handlers, processers, and marketers to obtain a
license from the Kentucky Department of Agriculture. 58 Violation
of the licensing requirements is penalized by the same provisions for
violations of state rules relating to marijuana. 59 These penalties are
found in state statutes for controlled substances. 60 The state
publishes a list of licensees, which can help facilitate the market for
hemp. 61 There are over one hundred processors and handlers
licensed, and, in 2018, farmers were paid over $17 million for hemp,
and over $50 million of gross products were sold.62 The acreage in
use is also rapidly increasing, approaching 10,000 acres. 63 Kentucky
Commissioner of Agriculture Ryan Quarles has noted that these
54

Id.
KY. DEP’T OF AGRIC., 2018 FARM BILL AND WHAT IT MEANS FOR HEMP IN
KENTUCKY (2018), http://www.kyagr.com/marketing/program_id/70/documents/H
EMP_OV_2018FarmBillandKentuckyHemp.pdf.
56
Id.
57
INDIGENOUS FOOD & AGRIC. INITIATIVE, THE 2018 FARM BILL AND THE LEGAL
LANDSCAPE FOR INDUSTRIAL HEMP PRODUCTION IN INDIAN COUNTRY 3, UNIV. OF
ARK. (2019), https://static1.squarespace.com/static/5aaaa2bd4611a0a9a6f8353d/t/5
c996196104c7b647468f5da/1553555912189/Final+IFAI+Hemp+Analysis.pdf
(showing that the nine states that still outlaw hemp are Idaho, Georgia, South
Dakota, Texas, Iowa, Louisiana, Mississippi, Ohio, and Connecticut); Fran Howard,
Hemp Producers Stuck Somewhere Between Two Farm Bills, AGRI PULSE (April 17,
2019), https://www.agri-pulse.com/articles/12104-regulatory-confusion-leaves-he
mp-producers-stuck-somewhere-between-two-farm-bills.
58
INDUSTRIAL HEMP RESEARCH PILOT OVERVIEW, KY. DEP’T OF AGRIC.,
https://www.kyagr.com/marketing/hemp-overview.html (last visited Nov. 27,
2019).
59
HEMP AND THE LAW, KY. DEP’T OF AGRIC., https://www.kyagr.com/marketing/he
mp-law.html (last visited Nov. 27, 2019).
60
KY. REV. STAT. ANN. § 218A.140 (West 2011).
61
2018 LICENSE HOLDER LIST (2018), KY. DEP’T OF AGRIC., https://www.kyagr.com/
marketing/documents/HEMP_OV_License-Holder-List_2018.pdf.
62
Bruce Schreiner, Hemp is Growing Like Crazy in Kentucky. Just Look at Last
Year’s Sales, COURIER J. (March 18, 2019), https://www.courier-journal.com/story/
news/2019/03/18/kentucky-hemp-sales-surged-2018-ryan-quarles-says/320199500
2/.
63
Id.
55
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figures represent a small portion of the state’s total agricultural
production, but the program’s goal was to ensure that Kentucky
could gain a lead on the market when it became legal to start
production and interstate transport. 64
The hemp provisions found in the 2018 Farm Bill have not
yet been enacted by the United States Department of Agriculture
(“USDA”). Until enacted, the market needs to operate under the
rules from the 2014 bill. Growers have major questions about crop
insurance, organic certification, interstate transportation, and
banking access. 65 Secretary of Agriculture Sonny Perdue estimated
that there will not be rules in time for this season, but they will be
ready for 2020 planting. 66 Growers are also having trouble getting
access to seeds to purchase, because they may have to be imported,
and growers need to ensure they have varieties with THC levels
below the legal threshold. 67
Due to the natural resilience of hemp, it is well-suited to
organic growing methods. 68 The USDA, which oversees the
National Organic Program, has allowed organic certification for
hemp, but not marijuana. 69 Allowing organic certification for hemp
byproducts like CBD could be beneficial, particularly if it is being
utilized as an ingredient in pharmaceuticals. Organic textiles are also
specially marketed, often for clothing. 70 Kentucky is home to the
Kentucky Organic Hemp Cooperative, one of the country’s first,
which has brought together farmers with smaller-than-usual acreage
who want to get market access. 71 Many of these farmers are growing
on land that has not recently been used for conventional crops, so
they do not have to wait through the three-year transitional period
that conventional farms need for organic certification. 72 Most of
64

Id.
Ryan McCrimmon, Washington Has Work to Do on CBD, Hemp, POLITICO (Feb.
26, 2019), https://www.politico.com/newsletters/morning-agriculture/2019/02/27/
washington-has-work-to-do-on-cbd-hemp-526036.
66
Ryan McCrimmon, Perdue, Senate Ag Talk Farm Bill Today, POLITICO (Feb. 28,
2019), https://www.politico.com/newsletters/morning-agriculture/2019/02/28/perd
ue-senate-ag-talk-farm-bill-today-528350.
67
Howard, supra note 57.
68
Seth Waggener, Organically Grown Hemp: Why Is It So Important?, PURE
SPECTRUM (Feb. 8, 2018), https://www.purespectrumcbd.com/organically-grownhemp-why-is-it-so-important/.
69
Barth, supra at note 29.
70
Does Organic Fabric Really Make a Difference?, HYDE YOGA BLOG (Aug. 1,
2019), https://yogahyde.com/yoga-wear-organic-vs-non-organic/.
71
Austyn Gaffney, Kentucky Farmers Gamble on the South’s First Organic Hemp
Cooperative, SOUTHERLY (Mar. 13, 2019), https://southerlymag.org/2019/03/13/ken
tucky-farmers-gamble-on-the-souths-first-organic-hemp-cooperative/.
72
Id.
65
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them are also growing hemp that will have CBD extracted because
as much as seventy percent of the state’s hemp is sold to the CBD
market. 73
IV. Current FDA Stance
A. Food, Drug, and Cosmetic Act Rules
At its core, the primary concern with the regulation of CBD
products is about consumer safety. The FDA does not want the
public taking products that have not been tested for purity or because
a company has made a wild claim about CBD’s ability to cure an
ailment.74 Concerns about the safety of food and drugs have existed
since time immemorial, but the first major U.S. legislation on the
subject was the 1906 Food and Drugs Act, passed by President
Theodore Roosevelt. 75 This Act cracked down on adulterated and
misbranded food and drugs. 76 The enactment was motivated by
problems in the industry, including a 1902 tragedy in St. Louis, when
thirteen children died after taking a contaminated drug. 77 The
children were administered a diphtheria antitoxin, but it was
contaminated with tetanus spores. 78
The Act was updated under the administration of President
Franklin Roosevelt, with the 1938 Federal Food, Drug, and Cosmetic
Act (“FDCA”). 79 Although the FDCA has been amended since its
inception, it remains the key starting point for understanding food
and drug regulation.

73

Id.
WHAT YOU NEED TO KNOW (AND WHAT WE’RE WORKING TO FIND OUT) ABOUT
PRODUCTS CONTAINING CANNABIS OR CANNABIS-DERIVED COMPOUNDS, INCLUDING
CBD, U.S. FOOD & DRUG ADMIN. (July 17, 2019), https://www.fda.gov/consumers/
consumer-updates/what-you-need-know-and-what-were-working-find-out-aboutproducts-containing-cannabis-or-cannabis.
75
MILESTONES IN U.S. FOOD LAW, N.D. STATE UNIV., https://www.ag.ndsu.edu/food
law/overview/history/milestones (last visited Dec.2, 2019).
76
HOW DID THE FEDERAL FOOD, DRUG, AND COSMETIC ACT COME ABOUT, U.S.
FOOD & DRUG ADMIN. (Mar. 28, 2018), https://www.fda.gov/about-fda/fda-basics/h
ow-did-federal-food-drug-and-cosmetic-act-come-about.
77
Linda Bren, The Road to the Biotech Revolution – Highlights of 100 Years of
Biologics Regulation, FDA CONSUMER MAG. 1 (Jan.-Feb. 2016), https://www.fda.go
v/files/about%20fda/published/The-Road-to-the-Biotech-Revolution--Highlights-o
f-100-Years-of-Biologics-Regulation.pdf.
78
PETER BARTON HUTT ET AL., FOOD & DRUG LAW 6–7 (Robert C. Clark et al. eds.,
4th ed. 2014).
79
HISTORIES OF PRODUCT REGULATION: THE 1938 FOOD, DRUG, AND COSMETIC ACT,
U.S. FOOD & DRUG ADMIN. (Jan. 31, 2019), https://www.fda.gov/about-fda/historie
s-product-regulation/1938-food-drug-and-cosmetic-act.
74
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The FDCA defines drugs as “articles intended for use in the
diagnosis, cure, mitigation, treatment, or prevention of disease in
man or other animals and articles (other than food) intended to affect
the structure or any function of the body of man or other animals.”80
Before any drug can be sold, manufacturers submit an application to
the FDA Center for Drug Evaluation and Research (CDER). 81 New
products are submitted under a new drug application; however, there
are many other types of approval processes, including for
investigational new drugs, therapeutic biologics, and over-thecounter drugs. 82 All of this application information will help the
FDA make a decision about approved doses, potential interactions
with other drugs, side effects that require warnings, and whether a
drug can be used continuously. 83
Although the 2018 Farm Bill removed hemp from DEA
oversight, it did not modify the FDA’s authority on cannabis
products or compounds. 84 Cannabis remains a Schedule I drug
according to the DEA, indicating no accepted medical use. 85
However, the FDA has approved one cannabis-derived drug and
three “cannabis-related” drugs. 86 The only approved drug with CBD
as an active ingredient is Epidiolex, and it was approved to treat
seizures in children suffering from Lennox-Gastaut or Dravet
syndrome. 87 The cannabis-derived drugs rely on synthetic THC,
either dronabinol or nabilone. The drugs are Marinol, Syndros, and
Cesamet. 88 The first two have been useful in combatting appetite
loss in AIDS patients. 89 Cesamet was approved for chemotherapy
patients to reduce nausea and vomiting from the treatment. 90

Federal Food, Drug, And Cosmetic Act, 21 U.S.C. § 321 (2016).
HOW DRUGS ARE DEVELOPED AND APPROVED, U.S. FOOD & DRUG ADMIN. (Jan. 7,
2019), https://www.fda.gov/drugs/development-approval-process-drugs/how-drugs
-are-developed-and-approved.
82
Id.
83
Id.
84
FDA REGULATION OF CANNABIS AND CANNABIS-DERIVED PRODUCTS: QUESTIONS
AND ANSWERS, FOOD & DRUG ADMIN. (Apr. 2, 2019), https://www.fda.gov/newsevents/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products
-questions-and-answers [hereinafter U.S. FOOD & DRUG ADMIN., REGULATION OF
CANNABIS].
85
Id.
86
Id.
87
Id.
88
Id.
89
Id.
90
Valeant Pharmaceuticals, Cesamet FDA Application, U.S. FOOD & DRUG ADMIN.
(May 2006), https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018677s0
11lbl.pdf.
80
81

84
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The trial conducted for epilepsy, which led to the approval
of Epidiolex, was supported by the drug manufacturer GW
Pharmaceuticals. 91 This presents a challenge for drug development–
large pharmaceutical companies have significant resources to pour
into research and development, go through the lengthy
administrative process to get a drug approved by the FDA, and
conduct testing to ensure they have a pure and safe product. Once
hemp research is less restricted, it is possible that these large
companies may try to get in on the market for legal drugs first,
capturing most of the revenue. However, an increase in the number
of approved hemp-derived drugs could create a stable market for
farmers. 92
The FDA approval of CBD as an active ingredient in
Epidiolex was a victory for the patients it will help. The market for
CBD supplements and food products was hindered, however,
because of FDCA rules which restrict the use of active ingredients in
FDA-approved drugs for food and dietary supplements. A dietary
supplement can contain an herb or botanical, but because it is an
active ingredient in a drug, CBD cannot be marketed as a dietary
supplement. 93 The FDA does have the discretion to go through the
notice and comment process to create a regulation allowing the sale
of dietary supplements with an approved-drug active ingredient. 94
However, the FDA has not chosen to exercise that discretion at this
time. 95
The same restriction outlaws the introduction of CBDcontaining products into interstate commerce. Section 331 of the
FDCA prohibits “[t]he introduction or delivery for introduction into
interstate commerce of any food to which has been added a drug
approved under section 355 of this title.” 96 Similar to the rules on
supplements, the FDA Secretary can use his discretion to issue a
regulation that allows the use of the drug in food. 97 There are already
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foods derived from hemp, and some, like hempseed, are easy to
find. 98
The interest in CBD for food products is not limited to
humans, either. Martha Stewart has formed a partnership with the
Canadian company “Canopy Growth” to launch a line of pet products
with CBD. 99 Another celebrity getting in on the market is rock star
Gene Simmons, who recently announced a CBD soda. 100 There are
many other edible products, topical products, and cosmetics that are
available, creating a lot of work for anyone attempting to enforce the
FDCA provisions, whether by preventing products from being
shipped in interstate commerce or completely stopping their sale. 101
An additional and interesting component of the market for
CBD products is how they move in commerce, either inter- or
intrastate. Earlier this year, the U.S. Postal Service (USPS) issued
an advisory about the mailing of CBD products. 102 Specifying that
these rules are temporary until the 2018 Farm Bill can be fully
implemented, the USPS is allowing shipment of CBD products under
certain circumstances. 103 In connection with the permitted research
production of hemp, mailers have to sign a statement certifying that
they have a valid license from the state department of agriculture in
the mail piece’s originating state.104
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and Beverage?, FOOD DIVE (Dec. 20, 2018), https://www.fooddive.com/news/nowthat-hemp-and-cbd-are-legal-what-comes-next-for-food-and-beverage/544354.
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select the first result).
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The FDA has been proactive in releasing information about
CBD and ensuring that the public can find and understand the
agency’s position. However, the momentum was stalled when FDA
Commissioner Scott Gottlieb announced in March that he would be
stepping down from his post in April. Gottlieb surprised many
people with his progressive work during his two years at the agency,
and he commented frequently on CBD in particular. 105 Because of
the limits of agency rulemaking, he suggested that Congress make
rules for the use of CBD in food products, because Congress could
act more quickly. 106 Gottlieb has since left the FDA, but the agency
moved ahead with a public hearing on May 31, 2019, with the
purpose to “obtain scientific data and information about the safety,
manufacturing, product quality, marketing, labeling, and sale of
products containing cannabis or cannabis-derived compounds.”107
At the hearing, presentations were made on topics ranging
from prescription interactions with cannabidiol to the use of hempderived ingredients in animal feed. 108 There were representatives
from consumer groups, state departments of agriculture, and
academia, among others. 109 The breadth of representation is a good
indication of the interest in creating regulations for cannabinoids and
creating a path for researchers to understand them. In a letter
addressed to Ned Sharpless, the acting commissioner of the FDA
after Gottlieb’s departure, a bipartisan group of Congressional
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representatives addressed the issue of CBD in food products.110 They
specifically proposed that the agency create an interim final rule for
the use of CBD in food products and dietary supplements in addition
to creating enforcement guidance and standards evaluating the safety
and accuracy of labeling. 111
The agency rulemaking process has many layers and can
seem quite complex, but every step is designed to ensure interested
parties can make their voice heard and that the agency can gather
appropriate technical information before promulgating a new rule.
Agencies publish a proposed rule or Notice of Proposed Rulemaking
(“NPRM”) in the Federal Register.112 Comment periods are typically
thirty to sixty days, but can be longer if the rule is particularly
complicated. 113 The upcoming public meeting on CBD will allow
people to share comments and information with the FDA, and the
agency is also taking written comments. A final rule should be based
on the entire rulemaking record, including these public comments.
Former Commissioner Gottlieb expanded on the potential of
rulemaking for CBD in an interview with the Brookings Institution
in March. 114 He stated that a standard rule takes “two to three years,”
and that he didn’t believe he could have accomplished rule formation
during his tenure, nor will the person who succeeds him. 115 Gottlieb
considers a rule for CBD in food to be novel and complex, because
it has already been used in a drug and was not previously approved
for use in food. 116 He also described the imminent creation of a
workgroup that would consider methods for Congress to create a
legal route, noting that this was done for human growth hormone and
fish oil. 117
The FDA has less control over dietary supplements than it
does over prescription drugs. Premarket approval or notification to
the FDA is limited, and the labeling rules are more expansive than
110
See Letter from Cong. of the United States to Ned Sharpless, Acting Comm’r,
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es/pingree_comer_cbd_letter_to_fda_9.19.19.pdf.
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those for prescription drugs. 118 Presently, there are companies that
market CBD and label it as supplements.119 Medterra, the company
that sources hemp from Kentucky, labels its products as
supplements. 120 The company does list a disclaimer at the bottom of
every web page that reads: “[r]epresentations regarding the efficacy
and safety of Medterra have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose,
prevent, treat, or cure any disease.”121 This has not stopped many
reviews from extolling the uses of the product for joint paint, anxiety,
hearing loss, and other issues. 122 The company ships to every state
in the U.S. and internationally.
Other companies advertising CBD supplements are easy to
find. The FDA has issued warning letters to numerous companies,
most of them for making unsubstantiated therapeutic claims about
the products for sale. 123 Warning letters give businesses time to take
corrective action before more serious consequences are imposed,
including product seizures or injunctions to halt the sale of items. 124
At the local and state level, health departments are cutting
into the sales of CBD in food. The Los Angeles County Health
Department issued its own guidance for restaurants, noting that
beginning in July 2019, points would be deducted on inspections for
selling food products adulterated with CBD. 125 One reason that
health officials are concerned is their belief that it can be difficult for
customers to differentiate products with and without CBD and the
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relative dosage in each product. 126 Acting under rules created for the
state’s medical marijuana program, officials from the Ohio
Department of Agriculture, Health Departments, and Policy have
visited stores and instructed them to stop selling CBD products or
risk having them seized. 127 The state’s law prohibits the sale of CBD
except in a licensed dispensary.128
Despite the de-scheduling of hemp, there can still be a stigma
associated with the consumption of hemp products. Consumers of
untested products also run the risk of testing positively for THC if
they are drug-tested, which can lead to serious consequences,
especially for work-related drug testing. 129 Some evidence shows
that consuming large amounts of CBD can yield a false positive.130
One expert in cannabis testing has clarified that most drug tests are
designed for finding THC, not other cannabinoids. 131 This is an
extremely discrete issue related to CBD consumption, so most people
would be better off locating information related to their specific
situation rather than relying on anecdotal information online.
V. Why should the FDA make rules for CBD?
The CBD market is not slowing down, and full
implementation of the 2018 Farm Bill is likely to expand it. The
FDA needs to make rules for consumer safety and to allow the
regulated creation of new drugs. The FDA can create rules for testing
products, creating a guarantee that a product is CBD, verifying the
levels of THC, and confirming product purity. 132 Access to quality
CBD products will also assist researchers, who can conduct approved
trials for new drugs and therapies that use CBD. Researchers at
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Johns Hopkins University are planning a clinical trial that will test
the potential benefits of CBD for smoking cessation. 133
Many potential benefits have been advertised, but not as
much focus has been put on the side effects. The listed side effects
of Epidiolex can include: decreased appetite, diarrhea, rashes, and
lower sleep quality. 134 Consumers also need guidance on dosing and
the variety of ingestion methods that could change the effectiveness
of a CBD drug. Research into CBD could also yield information
about other cannabinoids and a new understanding of the ensemble
effect in cannabinoids.
It is possible for research to be conducted with synthetic
cannabinoids. 135 The FDA-approved, cannabis-related drugs rely on
synthetic cannabinoids. 136 More recently, yeast has been used to
produce synthetic THC and CBD. 137 The obvious benefits are for
companies that want to begin research without cultivating hemp and
also ensure that the CBD is uncontaminated by THC. There is also
an opportunity to produce other synthetic cannabinoids and begin to
understand how many there actually are, potentially with more
benefits than what we are already aware of. 138 If synthetic CBD were
marketed, though, regulators would do right by consumers by
requiring a new name for the synthetic chemical, or a clear label that
indicates it is not a naturally-derived product.
VI. How should CBD be treated?
Regulators have many options for designing CBD rules. The
most formal process, and what would allow the most public input,
would be agency rulemaking. However, the agency could, through
rulemaking, use its discretion to allow the use of CBD in food
products and supplements, despite it not being used in either of these
products prior to the approval of Epidiolex. It also seems likely that
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there will be more research on the therapeutic value of CBD, so
Epidiolex will not be the only drug on the market for very long.
In addition to his comments supporting Congressional action
on the regulation, Gottlieb envisioned it as a tier or schedule of
concentrations for different products containing CBD, in part
because the side effects at different concentrations are not yet studied
and understood. 139 Congress could authorize the use in food and
supplements and then direct the FDA to establish the acceptable
thresholds for each product. 140 The collaboration between Congress
and the agency is not uncommon and would be the fastest way to
reach at least a temporary resolution until the FDA can solidify rules.
Gottlieb also believes that the committee will have recommendations
by the summer, 141 which would be prior to the full 2018 Farm Bill
implementation. If producers of CBD products have a better idea of
their legality, it will also give farmers some clarity on the market for
hemp.
VII. Conclusion
CBD has captured the interest of many different groups and
created a headache for federal and state agencies. This is an exciting
product, simply because of its untapped potential. It is, of course,
added to the long list of useful hemp products, providing farmers
with a new way to use their crops. The FDA and Congress should
work together to create rules that allow food and drug producers to
each have a piece of the market and provide consumers with tools for
health and overall wellness.
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